Biosino Bio-Technology & Science Inc

HKSE • Healthcare • Diagnostics & Research • Quote as of 10/22/2026

Company Profile

IndustryDiagnostics & Research

SectorHealthcare

ExchangeHKSE

Market Capitalization434.12 mln

Float64.29 mln

Earnings Date03/31/2027

Piotroski F-Score

2 / 9

Weak

Beneish M-Score

-2.92

Likely reliable

Relative Strength

45 / 100

Slightly lagging

Debt / Equity

1.07

Elevated leverage

Pre-Tax Margin

-36%

Deeply loss-making

ROE

-35.76

Deeply negative

Business Description

Founded in Beijing in 1988, Biosino Bio-Technology and Science Incorporation produces and distributes a broad range of laboratory testing products across Mainland China, including diagnostic reagents, test kits, and medical analyzers. The company also delivers medical inspection services and sells medical instruments, supported by a strategic partnership with Xiaoshou Medical Technology Co. Ltd.

Key Fundamentals

EPS-0.32

ROE-35.76

ROIC-12.56

ROA-11.22

EBITDA, mln-54.04

EV / EBITDA-10.45

EV / EBIT-8.86

Revenue, mln192

EV / Revenue2.95

Quote Details

Last 3.05

Change -0.07 (-2.24%)

Open 2.96

Volume 8,000

Turnover 24,400

Average Volume 21,048

Financial Ratios

Pre-Tax Profit Margin-36

Current Ratio0.76

Price / Book4.01

Price / Tangible Book4.72

Debt / Equity1.07

Price / Sales2.42

Financial Strength

Altman Z-Score-0.1

Piotroski F-Score 2 / 9

Beneish M-Score-2.92

Price to Intrinsic Value3.53

Price Performance & Relative Strength

Period	Price Performance	Relative Strength
1 Week	-6.44%	37 / 100
1 Month	-7.01%	53 / 100
2 Months	22.49%	91 / 100
6 Months	-17.57%	50 / 100
1 Year	232%	97 / 100